These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 3938854)
21. [Nocturnal hypoxemia and hypercapnia in patients with chronic obstructive ventilation disorder. Therapy with almitrine, a peripheral chemoreceptor stimulator]. Rühle KH; Köhler D; Huber G; Matthys H Prax Klin Pneumol; 1985 Jun; 39(6):197-203. PubMed ID: 2862627 [No Abstract] [Full Text] [Related]
22. [The effect of almitrine dimesylate on pulmonary hemodynamics in healthy subjects and in patients with chronic obstructive bronchitis]. Ansquer JC Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():409-10. PubMed ID: 2902612 [No Abstract] [Full Text] [Related]
23. [Long-term (6 months) treatment of chronic bronchitis with respiratory insufficiency using almitrine dimesylate. Double-blind study versus placebo]. Paramelle B; Joubert C; Dain MP Presse Med; 1984 Oct; 13(34):2094-8. PubMed ID: 6149538 [TBL] [Abstract][Full Text] [Related]
24. [Treatment of hematosis disorders in chronic obstructive bronchitis with almitrine bismesilate]. Raimondi GA Medicina (B Aires); 1987; 47(6):687-8. PubMed ID: 3504999 [No Abstract] [Full Text] [Related]
25. Effects of almitrine bismesylate on chemosensitivity in patients with chronic airways obstruction. Stanley NN; Pieczora JA; Pauly N Eur J Respir Dis Suppl; 1983; 126():233-7. PubMed ID: 6426992 [TBL] [Abstract][Full Text] [Related]
26. Cardiopulmonary effects of a single oral dose of almitrine at rest and on exercise in patients with hypoxic chronic airflow obstruction. Simonneau G; Meignan M; Denjean A; Raffestin B; Harf A; Prost JF Chest; 1986 Feb; 89(2):174-9. PubMed ID: 2867861 [TBL] [Abstract][Full Text] [Related]
27. [Treatment of hematosis disorders in chronic obstructive bronchitis with almitrine bismesylate]. González Montaner LJ Medicina (B Aires); 1986; 46(6):739-41. PubMed ID: 3306258 [No Abstract] [Full Text] [Related]
28. Almitrine bismesylate and hypoxemia in COPD patients (results of an Italian multicentric trial). Vulterini S; Dardes N; Moreo GC; Chianese R; Maiorano V; Carnimeo N Eur J Respir Dis Suppl; 1986; 146():677-83. PubMed ID: 3536561 [No Abstract] [Full Text] [Related]
29. Long term studies on almitrine bismesylate in COPD patients. Bourgouin-Karaouni D; Mercier J; Prefaut C Eur J Respir Dis Suppl; 1986; 146():695-701. PubMed ID: 3096767 [TBL] [Abstract][Full Text] [Related]
30. The effect of almitrine bismesylate on hypoxemia in chronic obstructive pulmonary disease. Bell RC; Mullins RC; West LG; Bachand RT; Johanson WG Ann Intern Med; 1986 Sep; 105(3):342-6. PubMed ID: 3527011 [TBL] [Abstract][Full Text] [Related]
31. Effect of almitrine bismesylate on the distribution of ventilation and mechanics of breathing in patients with COLD. Yernault JC; Van Muylem A; Noseda A; Ravez P; Paiva M Eur J Respir Dis Suppl; 1983; 126():265-70. PubMed ID: 6373341 [No Abstract] [Full Text] [Related]
32. [Pulmonary hemodynamic effects of intravenous almitrine in patients with chronic bronchitis and respiratory insufficiency]. Weitzenblum E; Ehrhart M; Schneider JC; Hirth C; Roegel E Bull Eur Physiopathol Respir; 1982; 18(5):765-73. PubMed ID: 6152773 [TBL] [Abstract][Full Text] [Related]
33. Peripheral nerve function in patients with chronic bronchitis receiving almitrine or placebo. Allen MB; Prowse K Thorax; 1989 Apr; 44(4):292-7. PubMed ID: 2548299 [TBL] [Abstract][Full Text] [Related]
34. [Almitrine dimesylate (vectarion)--the first representative of a new group of "synergetic" drugs--and its use in pulmonary pathology]. Mihalţan F Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1987; 36(3):209-19. PubMed ID: 2894713 [No Abstract] [Full Text] [Related]
36. Almitrine improves oxygenation when both awake and asleep in patients with hypoxia and carbon dioxide retention caused by chronic bronchitis and emphysema. Connaughton JJ; Douglas NJ; Morgan AD; Shapiro CM; Critchley JA; Pauly N; Flenley DC Am Rev Respir Dis; 1985 Aug; 132(2):206-10. PubMed ID: 4026044 [TBL] [Abstract][Full Text] [Related]
37. [Effects of oral almitrine on the distribution of VA/Q ratio in chronic obstructive lung diseases (author's transl)]. Castaing Y; Manier G; Varène N; Guénard H Bull Eur Physiopathol Respir; 1981; 17(6):917-32. PubMed ID: 7032629 [TBL] [Abstract][Full Text] [Related]
38. Effects of almitrine bismesylate on nocturnal hypoxemia in patients with chronic bronchitis and obesity. Marrone O; Milone F; Coppola P; Oddo S; Giannone G; Macaluso C; Bonsignore G Eur J Respir Dis Suppl; 1986; 146():641-8. PubMed ID: 3096764 [TBL] [Abstract][Full Text] [Related]
39. Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group. Voisin C; Howard P; Ansquer JC Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():169s-182s. PubMed ID: 3318971 [TBL] [Abstract][Full Text] [Related]
40. Double-blind comparison of the respiratory effects of parenteral lorazepam and diazepam in patients with chronic obstructive lung disease. Denaut M; Yernault JC; De Coster A Curr Med Res Opin; 1974-1975; 2(10):611-5. PubMed ID: 4156289 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]